TP53 and neoplasm: Reversing the effect of single mutations (R273H and R273C) in the p53 core domain is rescued by second-site suppressor mutations (T284R, S240R), which leads to a reactivation of the normal p53 activity (i.e., DNA binding, transcriptional activation and tumor-suppressing activity)[34].